title: Psychosis in epilepsy patients and other chronic medically ill patients and the role of cerebral pathology in the onset of psychosis: a clinical epidemiological study.
abstract: BACKGROUND
  In a 3-year epidemiological survey (N=2623) prevalence of psychosis in epilepsy patients as compared with other chronic medically ill patients is assessed.
  
  
  OBJECTIVE
  To explore the role of cerebral pathology as compared to the role of chronic burden of disease in the onset of psychosis.
  
  
  METHODS
  One thousand seven hundred fifty two patients with chronic medical disorders admitted to an Academic Hospital and 901 patients with epilepsy admitted to a tertiary care epilepsy clinic were assessed by CIDI, MINI and clinical psychiatric interview in a two stage screening survey. Medical files were searched for MRI scans about cerebral pathology. Poisson regression analysis was performed to estimate the relative risk for psychosis in both groups.
  
  
  RESULTS
  In total, 52 patients with prevalent psychosis were found: 49 (5.4%) in the epilepsy clinic and 3 (0.17%) in the Academic Hospital. Age range (18-88), mean age (42) and gender distribution (equal) were similar in both samples. RR is 8.37 (2.74, 25.52). In 16 of the 49 epilepsy patients, cerebral pathology existed with mainly temporal and frontal localisation and of childhood-onset vascular or infectious origin.
  
  
  CONCLUSIONS
  This finding suggests that in the onset of psychosis in epilepsy patients, the role of cerebral pathology, especially localized left temporal and frontal, is of strong etiological importance. The following epilepsy endophenotypes should be explored as factors in vulnerability for psychosis as well: frequent and severe epileptic activity; and psychotic reactions to certain AEDs, such as Topiramate and Lamotrigine. Burden of disease does not seem to play an important role.
authors.affiliation: Netherlands institute of Mental Health and Addiction, PO Box 725, 3500 AS Utrecht, The Netherlands. cfeltz@trimbos.nl
authors.forename: C M
authors.initials: CM
authors.lastname: van der Feltz-Cornelis
authors.forename: A P
authors.initials: AP
authors.lastname: Aldenkamp
authors.forename: H J
authors.initials: HJ
authors.lastname: Adèr
authors.forename: A
authors.initials: A
authors.lastname: Boenink
authors.forename: D
authors.initials: D
authors.lastname: Linszen
authors.forename: R
authors.initials: R
authors.lastname: Van Dyck
mesh_terms: D000328:Adult; D017668:Age of Onset; D002540:Cerebral Cortex / Q000473:pathology*; D002908:Chronic Disease / Q000453:epidemiology; D015897:Comorbidity; D039721:Diagnostic and Statistical Manual of Mental Disorders; D016021:Epidemiologic Studies; D004827:Epilepsy / Q000150:complications / Q000453:epidemiology / Q000473:pathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011618:Psychotic Disorders / Q000150:complications / Q000453:epidemiology / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies